TechTalk: Expanding access to at-home STI testing with FDA 510(k) cleared urine collection kit
Friday, October 16 at 16:30 BST | 17:30 CEST | 11:30 EDT | 08:30 PDT
Explore the significance of the FDA 510(k) clearance of the Colli-Pee™•Dx Urine Collection Kit and its role in advancing patient-centred STI testing.
By enabling at-home collection of first-void urine specimens, the Colli-Pee™•Dx Urine Collection Kit has the potential to improve access to STI laboratory testing by reducing barriers associated with clinic-based testing and supporting decentralized testing programs.
In this SelectScience® TechTalk, explore the science behind standardized first-void urine collection, the importance of sample quality for reliable STI laboratory testing, and the role of NucleoPrecision™ technology in sample stabilization. Learn how the kit can benefit laboratories and healthcare organizations through consistent sample collection, streamlined mail-based workflows, and compatibility with existing molecular testing platforms.
Register now to learn how the Colli-Pee™•Dx Urine Collection Kit combines patient convenience with laboratory-quality sample collection to help expand access to STI testing, encourage screening participation, and support broader public health objectives.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.
Speakers
Who should attend?
- Clinical and diagnostic laboratory professionals working in national, regional, hospital, and high-volume testing laboratories.
- Laboratory directors, managers, and technicians looking to streamline sample collection, improve workflow efficiency, and expand STI testing services.
- At-home testing providers and healthcare organizations seeking to improve patient access to STI screening through reliable, mail-based sample collection.
- Molecular diagnostics specialists using Roche cobas systems or other molecular testing platforms who are interested in incorporating at-home urine collection into existing workflows.
- R&D, quality assurance, and regulatory affairs professionals involved in developing, validating, and implementing diagnostic solutions.
- Senior commercial and operational decision-makers, including executives in procurement, sales, marketing, and business development, evaluating new opportunities in decentralized diagnostics.
Featured products
Request Quote for All Products
Colli-Pee™•Dx Urine Collection Kit
DNA Genotek Inc.The Colli-Pee™•Dx Urine Collection Kit is an FDA 510(k)-cleared device for standardized volumetric collection, stabilization, and transport of first-void urine for laboratory STI testing.
What will this webinar cover?
Key learning objectives:
- Explore how at-home sample collection can improve access to STI testing and reduce barriers to screening.
- Understand the science behind Colli-Pee™•Dx Urine Collection Kit, including standardized first-void urine collection and sample stabilization.
- Discover how laboratories and healthcare organizations can benefit from streamlined workflows, consistent sample quality, and decentralized testing programmes.
Join the TechTalk to get answers to these questions:
- Why is FDA 510(k) clearance of the Colli-Pee™ •Dx kit significant?
- How can at-home first-void urine collection improve access to STI testing?
- Why is standardized sample collection important for reliable results?
- How does NucleoPrecision™ technology support sample stabilization?
- How can laboratories integrate the kit into mail-based molecular testing workflows?